| Market Cap | 152M 131M 123M 112M 211M 14.41B 212M 1.46B 567M 7.33B 570M 558M 24.31B | P/E 2027 * |
-
| P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 129M 111M 104M 95.14M 179M 12.22B 180M 1.23B 481M 6.21B 483M 473M 20.6B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
99.05% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript : Depomed Inc
| 1 day | -9.45% |
| Director | Title | Age | Since |
|---|---|---|---|
Ravi Yadavar
BRD | Director/Board Member | 26 | 16/06/2026 |
Punit Patel
BRD | Director/Board Member | - | 16/06/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -9.45% | +3.54% | - | - | 152M | |
| +0.95% | -1.51% | +59.34% | +109.87% | 1,034B | |
| +1.38% | +1.67% | +54.17% | +70.85% | 654B | |
| -0.45% | -1.47% | +22.23% | +77.30% | 459B | |
| +0.62% | -5.00% | +33.55% | +35.80% | 343B | |
| +0.37% | +3.04% | +29.49% | +47.19% | 307B | |
| +0.28% | -1.93% | +0.79% | +12.24% | 251B | |
| -0.27% | -0.62% | +52.51% | +72.27% | 237B | |
| +2.64% | -1.05% | -15.82% | -53.96% | 202B | |
| -0.02% | +1.04% | +32.76% | +99.08% | 186B | |
| Average | -0.40% | -2.88% | +29.89% | +52.29% | 407.95B | |
| Weighted average by Cap. | +0.68% | -3.31% | +38.96% | +68.06% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 400K 345K 325K 296K 556K 37.96M 559K 3.84M 1.49M 19.31M 1.5M 1.47M 64.03M | - |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
